Close
Close

Life discovered.

Life diagnosed.

Close

Life discovered.

Life diagnosed.

Close

Life discovered.

Life diagnosed.

Close

Life discovered.

Life diagnosed.

Close

Life discovered.

Life diagnosed.

Gastrointestinal - Healthcare Acquired Infections

C. difficile

Our C. difficile testing portfolio is flexible to match the way your organization works. Pick your platform below.

Premier®
Premier® C. difficile GDH
Enzyme immunoassay for the detection of Clostridium difficile GDH in stool specimens
Learn More
Revogene®
Revogene® C. difficile
Improves satisfaction among patients and physicians by providing rapid, accurate, actionable results for the detection of Clostridium difficile infection (CDI)
Learn More
ImmunoCard®
Immunocard® Toxins A&B
A rapid, sensitive enzyme immunoassay for the detection of Clostridium difficile toxins A and B in stool specimens.
Learn More
Premier®
Premier® Toxins A&B
Enzyme Immunoassay for the detection of Clostridium difficile toxin A and toxin B in stool specimens.
Learn More
Alethia®
Alethia® C. difficile
Molecular assay for the detection of C. difficile. Alethia® provides a quick, accurate and reliable molecular assay for C. difficile detection.
Learn More
ImmunoCard STAT®
Immunocard STAT!® C. difficile GDH-AB
A rapid, qualitative, immunochromatographic assay for the simultaneous detection, in human stool, of Clostridium difficile Glutamate Dehydrogenase antigen (GDH, also called “common antigen”) and Clostridium difficile Toxins A and B.
Learn More
ImmunoCard®
Immunocard® C. difficile GDH
A rapid, sensitive enzyme immunoassay for the detection of Clostridium difficile antigen (GDH) in stool specimens.
Learn More

Definitive answers, confident results.

Contact Sales

Definitive answers, confident results.

Contact Sales

One Size Doesn't Fit All.

Work together to minimize the impact of C. difficile with the only company to provide a complete C. difficile testing portfolio. Let’s customize a diagnostic approach to fit your unique needs. We'll work with you to find the right diagnostic approach for C. difficile and reduce healthcare costs associated with isolation, antibiotics, and outbreaks.

  • Group 13 Created with Sketch.
    Increase test sensitivity with one-step Alethia Molecular Solution
  • Group 19 Created with Sketch.
    Reduce costs with two-step solution - Alethia Molecular + GDH Screen
  • Group 19 Created with Sketch.
    Improve performance with two-step solution - Alethia Molecular+ Toxin test
  • Group 12 Created with Sketch.
    Eliminate negative results quickly with three-step solution - GDH screen + Alethia + Toxin test

Get In Touch With Us

Contact Us

Welcome to

Please select your country to continue

Continue
CN
CN